oxidopamine has been researched along with Body Weight in 121 studies
Oxidopamine: A neurotransmitter analogue that depletes noradrenergic stores in nerve endings and induces a reduction of dopamine levels in the brain. Its mechanism of action is related to the production of cytolytic free-radicals.
oxidopamine : A benzenetriol that is phenethylamine in which the hydrogens at positions 2, 4, and 5 on the phenyl ring are replaced by hydroxy groups. It occurs naturally in human urine, but is also produced as a metabolite of the drug DOPA (used for the treatment of Parkinson's disease).
Body Weight: The mass or quantity of heaviness of an individual. It is expressed by units of pounds or kilograms.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Previously we showed that intermittent administration of nicotine (NIC) in the dark phase decreased food intake and body weight and this could be blocked when the NIC receptor antagonist mecamylamine was infused into the fourth ventricle." | 7.74 | Nicotine's attenuation of body weight involves the perifornical hypothalamus. ( Bellinger, LL; Guan, G; Kramer, PR; Wellman, PJ, 2007) |
| "Although we could not establish an association between the anxiety level of rats with either the onset or severity of LID, our results showed that citalopram was able to mediate a partial alleviation in LID after chronic treatment, and the extent of recovery was negatively correlated to the anxiety measures of individual animals." | 7.74 | The role of anxiety in the development of levodopa-induced dyskinesias in an animal model of Parkinson's disease, and the effect of chronic treatment with the selective serotonin reuptake inhibitor citalopram. ( Barker, RA; Kuan, WL; Zhao, JW, 2008) |
| "Previously we showed that intermittent administration of nicotine (NIC) in the dark phase decreased food intake and body weight and this could be blocked when the NIC receptor antagonist mecamylamine was infused into the fourth ventricle." | 3.74 | Nicotine's attenuation of body weight involves the perifornical hypothalamus. ( Bellinger, LL; Guan, G; Kramer, PR; Wellman, PJ, 2007) |
| "Although we could not establish an association between the anxiety level of rats with either the onset or severity of LID, our results showed that citalopram was able to mediate a partial alleviation in LID after chronic treatment, and the extent of recovery was negatively correlated to the anxiety measures of individual animals." | 3.74 | The role of anxiety in the development of levodopa-induced dyskinesias in an animal model of Parkinson's disease, and the effect of chronic treatment with the selective serotonin reuptake inhibitor citalopram. ( Barker, RA; Kuan, WL; Zhao, JW, 2008) |
| "Parkinson's disease is a neurodegenerative disorder that affects the central nervous system and is mainly characterized by the loss of dopaminergic neurons and pro-oxidant mechanisms." | 1.56 | Eugenol and its association with levodopa in 6-hydroxydopamine-induced hemiparkinsonian rats: Behavioural and neurochemical alterations. ( Aragão Catunda Junior, FE; Basto Souza, R; da Cunha Ferreira, NM; de Sousa Dos Reis, TD; Hardy Lima Pontes, N; Maranguape Silva da Cunha, R; Moreira Vasconcelos, CF; Vasconcelos Aguiar, LM, 2020) |
| " In the full lesion model, vehicle dosing or liraglutide treatment was applied for a total of six weeks starting three weeks pre-lesion, or administered for three weeks starting on the lesion day." | 1.43 | Characterization of liraglutide, a glucagon-like peptide-1 (GLP-1) receptor agonist, in rat partial and full nigral 6-hydroxydopamine lesion models of Parkinson's disease. ( Barkholt, P; Fabricius, K; Hansen, HH; Jelsing, J; Knudsen, LB; Mikkelsen, JD; Pyke, C; Vrang, N, 2016) |
| "Patients with Parkinson's disease (PD) lose body weight primarily due to decreased body fat mass." | 1.37 | Possible regulatory factors for intra-abdominal fat mass in a rat model of Parkinson's disease. ( Aoyama, T; Arai, C; Kuranuki, S; Nakamura, T; Terada, S, 2011) |
| "SUN N8075 is a novel antioxidant with neuroprotective properties." | 1.35 | Protective effects of SUN N8075, a novel agent with antioxidant properties, in in vitro and in vivo models of Parkinson's disease. ( Adachi, T; Hara, H; Izuta, H; Matsunaga, N; Oida, Y; Oyagi, A; Shimazawa, M, 2008) |
| "Kainic acid (KA) was microiontophoretically applied into the mediodorsal division of PFC to damage intrinsic neurons, whereas in another group of rats, 6-hydroxydopamine (6-OHDA) was microiontophoretized into the same region to destroy catecholaminergic (CA) projection fiber terminals." | 1.31 | Alterations of conditioned taste aversion after microiontophoretically applied neurotoxins in the medial prefrontal cortex of the rat. ( Berta, B; Egyed, R; Hernádi, I; Karádi, Z; Lénárd, L; Petykó, Z; Vígh, J, 2000) |
| "Captopril was given (30 or 100 mg kg(-l) day(-l); p." | 1.31 | Angiotensin converting enzyme inhibition prevents trophic and hypertensive effects of an antagonist of adenosine receptors. ( Albino-Teixeira, A; Morato, M; Sousa, T, 2002) |
| " These results are consistent with previous work highlighting the importance of aberrant amine production in neurological disease and demonstrate that treatments that reduce endogenous melatonin bioavailability can ameliorate experimental PD." | 1.30 | A therapeutic role for melatonin antagonism in experimental models of Parkinson's disease. ( Armstrong, SM; Willis, GL, 1999) |
| "Body weight was monitored for 28 days after the infusion, after which rats were first tested in an exploration choice-box and then underwent a series of pharmacological challenges." | 1.27 | Comparative effects of infusions of 6-hydroxydopamine into nucleus accumbens and anterolateral hypothalamus induced by 6-hydroxydopamine on the response to dopamine agonists, body weight, locomotor activity and measures of exploration in the rat. ( Robbins, TW; Winn, P, 1985) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 46 (38.02) | 18.7374 |
| 1990's | 31 (25.62) | 18.2507 |
| 2000's | 23 (19.01) | 29.6817 |
| 2010's | 18 (14.88) | 24.3611 |
| 2020's | 3 (2.48) | 2.80 |
| Authors | Studies |
|---|---|
| Riedesel, AK | 1 |
| Helgers, SOA | 1 |
| Abdulbaki, A | 1 |
| Hatipoglu Majernik, G | 1 |
| Alam, M | 1 |
| Krauss, JK | 1 |
| Schwabe, K | 1 |
| Stefanidis, A | 1 |
| Lee, CMC | 1 |
| Greaves, E | 1 |
| Montgomery, MK | 1 |
| Arnold, M | 1 |
| Newn, S | 1 |
| Budin, AJ | 1 |
| Lemus, MB | 1 |
| Foldi, CJ | 1 |
| Burton, PR | 1 |
| Brown, WA | 1 |
| Lutz, TA | 1 |
| Watt, MJ | 1 |
| Oldfield, BJ | 1 |
| Moreira Vasconcelos, CF | 1 |
| da Cunha Ferreira, NM | 1 |
| Hardy Lima Pontes, N | 1 |
| de Sousa Dos Reis, TD | 1 |
| Basto Souza, R | 1 |
| Aragão Catunda Junior, FE | 1 |
| Vasconcelos Aguiar, LM | 1 |
| Maranguape Silva da Cunha, R | 1 |
| Li, SY | 1 |
| Wang, YL | 1 |
| Liu, WW | 1 |
| Lyu, DJ | 1 |
| Wang, F | 1 |
| Mao, CJ | 1 |
| Yang, YP | 1 |
| Hu, LF | 1 |
| Liu, CF | 1 |
| Willis, GL | 4 |
| Freelance, CB | 1 |
| Ouachikh, O | 1 |
| Dieb, W | 1 |
| Durif, F | 1 |
| Hafidi, A | 1 |
| Migliore, MM | 1 |
| Ortiz, R | 1 |
| Dye, S | 1 |
| Campbell, RB | 1 |
| Amiji, MM | 1 |
| Waszczak, BL | 1 |
| Horvathova, L | 1 |
| Tillinger, A | 1 |
| Sivakova, I | 1 |
| Mikova, L | 1 |
| Mravec, B | 2 |
| Bucova, M | 1 |
| Park, SE | 1 |
| Song, KI | 1 |
| Suh, JK | 1 |
| Hwang, D | 1 |
| Youn, I | 1 |
| Gálosi, R | 2 |
| Hajnal, A | 2 |
| Petykó, Z | 2 |
| Hartmann, G | 1 |
| Karádi, Z | 3 |
| Lénárd, L | 5 |
| Ma, D | 1 |
| Shuler, JM | 1 |
| Raider, KD | 1 |
| Rogers, RS | 1 |
| Wheatley, JL | 1 |
| Geiger, PC | 2 |
| Stanford, JA | 3 |
| Hansen, HH | 1 |
| Fabricius, K | 1 |
| Barkholt, P | 1 |
| Mikkelsen, JD | 1 |
| Jelsing, J | 1 |
| Pyke, C | 1 |
| Knudsen, LB | 1 |
| Vrang, N | 1 |
| Maya-López, M | 1 |
| Ruiz-Contreras, HA | 1 |
| de Jesús Negrete-Ruíz, M | 1 |
| Martínez-Sánchez, JE | 1 |
| Benítez-Valenzuela, J | 1 |
| Colín-González, AL | 1 |
| Villeda-Hernández, J | 1 |
| Sánchez-Chapul, L | 1 |
| Parra-Cid, C | 1 |
| Rangel-López, E | 1 |
| Santamaría, A | 1 |
| Kuranuki, S | 1 |
| Arai, C | 1 |
| Terada, S | 1 |
| Aoyama, T | 1 |
| Nakamura, T | 1 |
| Morris, JK | 2 |
| Bomhoff, GL | 1 |
| Lackovicova, L | 1 |
| Banovska, L | 1 |
| Bundzikova, J | 1 |
| Janega, P | 1 |
| Bizik, J | 1 |
| Kiss, A | 1 |
| Mai, B | 2 |
| Sommer, S | 1 |
| Hauber, W | 2 |
| Meyer, SG | 1 |
| Harris, RB | 1 |
| Nuckolls, AL | 1 |
| Worley, C | 1 |
| Leto, C | 1 |
| Zhang, H | 1 |
| Chao, OY | 1 |
| Pum, ME | 1 |
| Huston, JP | 1 |
| Mircoli, L | 1 |
| Fedele, L | 1 |
| Benetti, M | 1 |
| Bolla, GB | 1 |
| Radaelli, A | 1 |
| Perlini, S | 1 |
| Ferrari, AU | 1 |
| Filipov, NM | 1 |
| Cao, L | 1 |
| Seegal, RF | 1 |
| Lawrence, DA | 1 |
| Saura, J | 1 |
| Parés, M | 1 |
| Bové, J | 1 |
| Pezzi, S | 1 |
| Alberch, J | 1 |
| Marin, C | 1 |
| Tolosa, E | 1 |
| Martí, MJ | 1 |
| Brot, MD | 1 |
| Szczypka, MS | 1 |
| Reavell, R | 1 |
| Marck, BT | 1 |
| Matsumoto, AM | 1 |
| Palmiter, RD | 1 |
| Oben, JA | 1 |
| Roskams, T | 1 |
| Yang, S | 1 |
| Lin, H | 1 |
| Sinelli, N | 1 |
| Li, Z | 1 |
| Torbenson, M | 1 |
| Huang, J | 1 |
| Guarino, P | 1 |
| Kafrouni, M | 1 |
| Diehl, AM | 1 |
| Eslamboli, A | 1 |
| Cummings, RM | 1 |
| Ridley, RM | 1 |
| Baker, HF | 1 |
| Muzyczka, N | 1 |
| Burger, C | 1 |
| Mandel, RJ | 1 |
| Kirik, D | 3 |
| Annett, LE | 1 |
| Yao, KH | 1 |
| Qian, YR | 1 |
| Zhu, ZM | 1 |
| Sandstrom, MI | 1 |
| Nelson, CL | 1 |
| Bruno, JP | 1 |
| Yasuhara, T | 2 |
| Shingo, T | 2 |
| Kobayashi, K | 1 |
| Takeuchi, A | 1 |
| Yano, A | 1 |
| Muraoka, K | 2 |
| Matsui, T | 1 |
| Miyoshi, Y | 1 |
| Hamada, H | 2 |
| Date, I | 2 |
| Ishiwari, K | 1 |
| Weber, SM | 1 |
| Mingote, S | 1 |
| Correa, M | 1 |
| Salamone, JD | 1 |
| Rex, A | 1 |
| Fink, H | 1 |
| Kameda, M | 1 |
| Agari, T | 1 |
| Wen Ji, Y | 1 |
| Hayase, H | 1 |
| Borlongan, CV | 1 |
| Stricker, EM | 2 |
| Zimmerman, MB | 1 |
| Friedman, MI | 1 |
| Zigmond, MJ | 1 |
| Sherren, N | 1 |
| Pappas, BA | 2 |
| Kramer, PR | 1 |
| Guan, G | 1 |
| Wellman, PJ | 1 |
| Bellinger, LL | 1 |
| Fujikawa, T | 1 |
| Matsumura, S | 1 |
| Yamada, H | 1 |
| Inoue, K | 1 |
| Fushiki, T | 1 |
| Kuan, WL | 1 |
| Zhao, JW | 1 |
| Barker, RA | 1 |
| Oyagi, A | 1 |
| Oida, Y | 1 |
| Hara, H | 2 |
| Izuta, H | 1 |
| Shimazawa, M | 1 |
| Matsunaga, N | 1 |
| Adachi, T | 1 |
| Clevers, J | 1 |
| Morris, JL | 1 |
| Concannon, JT | 2 |
| Braughler, JM | 1 |
| Schechter, MD | 2 |
| Chatelain, P | 1 |
| Robberecht, P | 1 |
| Camus, JC | 1 |
| De Neef, P | 1 |
| Waelbroeck, M | 1 |
| Roba, J | 1 |
| Christophe, J | 1 |
| Brenner, E | 2 |
| Mirmiran, M | 2 |
| Uylings, HB | 2 |
| Van der Gugten, J | 2 |
| Robbins, TW | 2 |
| Roberts, DC | 1 |
| Koob, GF | 3 |
| Heffner, TG | 1 |
| Seiden, LS | 1 |
| Nance, DM | 1 |
| Pelleymounter, MA | 1 |
| Lorden, JF | 2 |
| Ito, Y | 1 |
| Mine, K | 1 |
| Ago, Y | 1 |
| Nakagawa, T | 1 |
| Fujiwara, M | 1 |
| Ueki, S | 1 |
| Erinoff, L | 1 |
| Kelly, PH | 1 |
| Basura, M | 1 |
| Snodgrass, SR | 1 |
| Gruenthal, M | 1 |
| Palfai, T | 1 |
| Armstrong, D | 1 |
| Courtney, CL | 1 |
| Hansen, S | 1 |
| Köhler, C | 1 |
| Smith, GC | 2 |
| Hahn, Z | 2 |
| Goldenring, JR | 1 |
| Shaywitz, BA | 1 |
| Wool, RS | 1 |
| Batter, DK | 1 |
| Anderson, GM | 1 |
| Cohen, DJ | 1 |
| Hashimoto, I | 1 |
| Knudson, MB | 1 |
| Noble, EG | 1 |
| Klug, GA | 1 |
| Gollnick, PD | 1 |
| Hall, NR | 1 |
| McClure, JE | 1 |
| Hu, SK | 1 |
| Tare, NS | 1 |
| Seals, CM | 1 |
| Goldstein, AL | 1 |
| Segler-Stahl, K | 1 |
| Rahmann, H | 1 |
| Rösner, H | 1 |
| Kimura, Y | 1 |
| Miyake, K | 1 |
| Kitaura, T | 1 |
| Kihira, K | 1 |
| Fukuchi, H | 1 |
| Sakai, K | 1 |
| Gash, DM | 1 |
| Sullivan, RM | 1 |
| Wilson, DA | 1 |
| Lemon, C | 1 |
| Gerhardt, GA | 1 |
| Rassnick, S | 1 |
| Stinus, L | 2 |
| Van Muiswinkel, FL | 1 |
| Bol, JG | 1 |
| Ruijter, JM | 1 |
| Stoof, JC | 2 |
| Drukarch, B | 1 |
| Steinbusch, HW | 1 |
| Wolfarth, S | 1 |
| Konieczny, J | 1 |
| Smiałowska, M | 1 |
| Schulze, G | 1 |
| Ossowska, K | 1 |
| Toufexis, DJ | 1 |
| Walker, CD | 1 |
| Sallés, J | 1 |
| Gascón, S | 1 |
| Badia, A | 1 |
| Honrath, U | 1 |
| Veress, AT | 1 |
| Chong, CK | 1 |
| Sonnenberg, H | 1 |
| Labelle, M | 1 |
| Boulanger, Y | 1 |
| Fournier, A | 1 |
| St Pierre, S | 1 |
| Savard, R | 1 |
| Kolb, B | 1 |
| Stewart, J | 1 |
| Sutherland, RJ | 1 |
| Fendler, K | 1 |
| Kalra, PS | 1 |
| Dube, MG | 1 |
| Xu, B | 1 |
| Farmerie, WG | 1 |
| Kalra, SP | 1 |
| Qian, M | 1 |
| Johnson, AE | 1 |
| Södersten, P | 1 |
| Choi-Lundberg, DL | 1 |
| Lin, Q | 1 |
| Schallert, T | 1 |
| Crippens, D | 1 |
| Davidson, BL | 1 |
| Chang, YN | 1 |
| Chiang, YL | 1 |
| Qian, J | 1 |
| Bardwaj, L | 1 |
| Bohn, MC | 1 |
| Myrsén-Axcrona, U | 1 |
| Ahrén, B | 2 |
| Sundler, F | 2 |
| Rosenblad, C | 2 |
| Devaux, B | 1 |
| Moffat, B | 1 |
| Phillips, HS | 1 |
| Björklund, A | 2 |
| Armstrong, SM | 1 |
| Andringa, G | 1 |
| van Oosten, RV | 1 |
| Unger, W | 1 |
| Hafmans, TG | 1 |
| Veening, J | 1 |
| Cools, AR | 1 |
| Hernádi, I | 1 |
| Vígh, J | 1 |
| Egyed, R | 1 |
| Berta, B | 1 |
| Tavakoli-Nezhad, M | 1 |
| Barron, AJ | 1 |
| Pitts, DK | 1 |
| Kvist-Reimer, M | 1 |
| Sousa, T | 1 |
| Morato, M | 1 |
| Albino-Teixeira, A | 1 |
| Dunbar, JS | 1 |
| Hitchcock, K | 1 |
| Latimer, M | 1 |
| Rugg, EL | 1 |
| Ward, N | 1 |
| Winn, P | 4 |
| Fletcher, EC | 1 |
| Lesske, J | 1 |
| Culman, J | 1 |
| Miller, CC | 1 |
| Unger, T | 1 |
| Weissenborn, R | 1 |
| Murtha, SJ | 1 |
| Park, GA | 1 |
| Condon, KT | 1 |
| Szirtes, RM | 1 |
| Laventure, SI | 1 |
| Ally, A | 1 |
| Fink, DW | 2 |
| Horn, PT | 1 |
| Mirkin, BL | 2 |
| Itoh, H | 1 |
| Alper, RH | 1 |
| Buñag, RD | 1 |
| Nobrega, JN | 2 |
| Saari, MJ | 1 |
| Armstrong, JN | 1 |
| Reed, T | 1 |
| Konkol, RJ | 1 |
| Wesselmann, U | 1 |
| Karpus, WJ | 1 |
| Leo, GL | 1 |
| Killen, JA | 1 |
| Roerig, DL | 1 |
| Thomas, GD | 1 |
| O'Hagan, KP | 1 |
| Zambraski, EJ | 1 |
| Blunt, S | 1 |
| Jenner, P | 1 |
| Marsden, CD | 1 |
| van den Buuse, M | 1 |
| Head, GA | 1 |
| Korner, PI | 1 |
| Lau, C | 2 |
| Cameron, A | 1 |
| Antolick, L | 2 |
| Slotkin, TA | 3 |
| Hernandez, L | 1 |
| Hoebel, BG | 1 |
| Hou, QC | 1 |
| Seidler, FJ | 1 |
| Kavlock, RJ | 1 |
| Gray, JA | 1 |
| Orband-Miller, L | 1 |
| Queen, KL | 1 |
| Baker, FE | 1 |
| Cameron, AM | 1 |
| Haim, K | 1 |
| Nakada, T | 1 |
| Koike, H | 1 |
| Katayama, T | 1 |
| White, NM | 1 |
| Schultz, JE | 1 |
| Schmidt, BH | 1 |
| Snyder, GL | 1 |
| Coscina, DV | 1 |
| Hartgraves, SL | 1 |
| Randall, PK | 1 |
| Sims, JS | 1 |
| Kuenzel, WJ | 1 |
| Snapir, N | 1 |
| Rexroad, CE | 1 |
| Kurumaji, A | 1 |
| Takashima, M | 1 |
| Watanabe, S | 1 |
| Takahashi, K | 1 |
| Ankermann, H | 1 |
| Dowell, RT | 1 |
| Emerich, DF | 1 |
| Scalzo, FM | 1 |
| Enters, EK | 1 |
| Spear, NE | 1 |
| Spear, LP | 1 |
| Dunnett, SB | 1 |
| Lane, DM | 1 |
| Grzanna, R | 1 |
| Frondoza, CG | 1 |
| Otten, U | 1 |
| Bhakthavatsalam, P | 1 |
| Kamatchi, GL | 1 |
| Ghosh, MN | 1 |
| Swerdlow, NR | 1 |
| Lee, D | 1 |
| Vaccarino, FJ | 1 |
| Kelley, AE | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Cardiovascular and Metabolic Physiological Adaptations to Intermittent Hypoxia. Physiological Aspects and Expression of Receptors and Cellular Mediators[NCT02058823] | Phase 4 | 12 participants (Actual) | Interventional | 2013-08-07 | Terminated (stopped due to budget constraints) | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
1 review available for oxidopamine and Body Weight
| Article | Year |
|---|---|
Control of sensorimotor function by dopaminergic nigrostriatal neurons: influence on eating and drinking.
Topics: Animals; Blood Glucose; Body Weight; Brain Mapping; Corpus Striatum; Dopamine; Drinking Behavior; El | 1986 |
120 other studies available for oxidopamine and Body Weight
| Article | Year |
|---|---|
Severity Assessment of Complex and Repeated Intracranial Surgery in Rats.
Topics: Animals; Body Weight; Disease Models, Animal; Male; Oxidopamine; Parkinson Disease; Rats; Rats, Spra | 2023 |
Mechanisms underlying the efficacy of a rodent model of vertical sleeve gastrectomy - A focus on energy expenditure.
Topics: Animals; Body Weight; Energy Metabolism; Gastrectomy; Glucose; Humans; Male; Oxidopamine; Rats; Rats | 2023 |
Eugenol and its association with levodopa in 6-hydroxydopamine-induced hemiparkinsonian rats: Behavioural and neurochemical alterations.
Topics: Animals; Behavior, Animal; Body Weight; Brain; Disease Models, Animal; Eugenol; Glutathione; Levodop | 2020 |
Long-term Levodopa Treatment Accelerates the Circadian Rhythm Dysfunction in a 6-hydroxydopamine Rat Model of Parkinson's Disease.
Topics: Animals; Blotting, Western; Body Weight; Circadian Rhythm; Enzyme-Linked Immunosorbent Assay; Fluore | 2017 |
The effect of directed photic stimulation of the pineal on experimental Parkinson's disease.
Topics: Animals; Body Weight; Frontal Lobe; Light; Male; Movement; Oxidopamine; Parkinsonian Disorders; Phot | 2017 |
Differential behavioral reinforcement effects of dopamine receptor agonists in the rat with bilateral lesion of the posterior ventral tegmental area.
Topics: Adrenergic Agents; Analysis of Variance; Animals; Body Weight; Brain; Cocaine; Conditioning, Operant | 2013 |
Neurotrophic and neuroprotective efficacy of intranasal GDNF in a rat model of Parkinson's disease.
Topics: Administration, Intranasal; Animals; Body Weight; Cell Count; Disease Models, Animal; Dopaminergic N | 2014 |
Chemical sympathectomy increases neutrophil-to-lymphocyte ratio in tumor-bearing rats but does not influence cancer progression.
Topics: Animals; Body Weight; Disease Models, Animal; Disease Progression; Erythrocytes; Kaplan-Meier Estima | 2015 |
A time-course study of behavioral and electrophysiological characteristics in a mouse model of different stages of Parkinson's disease using 6-hydroxydopamine.
Topics: Action Potentials; Animals; Body Weight; Disease Progression; Immunohistochemistry; Male; Medial For | 2015 |
The role of catecholamine innervation in the medial prefrontal cortex on the regulation of body weight and food intake.
Topics: Adrenergic Agents; Animals; Body Weight; Dopamine; Drinking Water; Eating; Exploratory Behavior; Foo | 2015 |
Effects of discontinuing a high-fat diet on mitochondrial proteins and 6-hydroxydopamine-induced dopamine depletion in rats.
Topics: Animals; Body Weight; Corpus Striatum; Diet, Fat-Restricted; Diet, High-Fat; Dopamine; Glucose; Male | 2015 |
Characterization of liraglutide, a glucagon-like peptide-1 (GLP-1) receptor agonist, in rat partial and full nigral 6-hydroxydopamine lesion models of Parkinson's disease.
Topics: Animals; Antiparkinson Agents; Apomorphine; Body Weight; Disease Models, Animal; Dopamine; Dopamine | 2016 |
URB597 reduces biochemical, behavioral and morphological alterations in two neurotoxic models in rats.
Topics: Amidohydrolases; Animals; Apomorphine; Behavior, Animal; Benzamides; Body Weight; Carbamates; Inject | 2017 |
Possible regulatory factors for intra-abdominal fat mass in a rat model of Parkinson's disease.
Topics: Animals; Body Weight; Digestion; Disease Models, Animal; Insulin; Intra-Abdominal Fat; Lipogenesis; | 2011 |
Neurodegeneration in an animal model of Parkinson's disease is exacerbated by a high-fat diet.
Topics: Animals; Blood Glucose; Body Weight; Cholesterol; Chromatography, High Pressure Liquid; Dietary Fats | 2010 |
Chemical sympathectomy suppresses fibrosarcoma development and improves survival of tumor-bearing rats.
Topics: Animals; Body Weight; Fibrosarcoma; Humans; Immunoenzyme Techniques; Injections, Intraperitoneal; Ma | 2011 |
Motivational states influence effort-based decision making in rats: the role of dopamine in the nucleus accumbens.
Topics: Adrenergic Agents; Analysis of Variance; Animals; Behavior, Animal; Body Weight; Conditioning, Opera | 2012 |
Adrenergic influence on progesterone metabolism and cyclicity in the rat ovary: autotransplantation and chemical sympathectomy.
Topics: 3-alpha-Hydroxysteroid Dehydrogenase (B-Specific); 3-Hydroxysteroid Dehydrogenases; 3-Oxo-5-alpha-St | 1992 |
Sympathetic denervation of one white fat depot changes norepinephrine content and turnover in intact white and brown fat depots.
Topics: Adipose Tissue, Brown; Adipose Tissue, White; Animals; Body Weight; Epididymis; Groin; Injections; M | 2012 |
Tongue force and tongue motility are differently affected by unilateral vs bilateral nigrostriatal dopamine depletion in rats.
Topics: Analysis of Variance; Animals; Body Weight; Corpus Striatum; Dopamine; Functional Laterality; Muscle | 2012 |
Intact risk-based decision making in rats with prefrontal or accumbens dopamine depletion.
Topics: Analysis of Variance; Animals; Body Weight; Choice Behavior; Conditioning, Operant; Dopamine; Male; | 2012 |
The interaction between the dopaminergic forebrain projections and the medial prefrontal cortex is critical for memory of objects: implications for Parkinson's disease.
Topics: Animals; Body Weight; Dark Adaptation; Dopamine; Excitatory Amino Acid Agonists; Exploratory Behavio | 2013 |
Preservation of the baroreceptor heart rate reflex by chemical sympathectomy in experimental heart failure.
Topics: Adrenergic beta-Antagonists; Animals; Baroreflex; Blood Pressure; Body Weight; Bradycardia; Catechol | 2002 |
Compromised peripheral immunity of mice injected intrastriatally with six-hydroxydopamine.
Topics: Animals; Apomorphine; Body Weight; Corpus Striatum; Corticosterone; Dopamine; Hemocyanins; Hypersens | 2002 |
Intranigral infusion of interleukin-1beta activates astrocytes and protects from subsequent 6-hydroxydopamine neurotoxicity.
Topics: Animals; Astrocytes; Body Temperature; Body Weight; Cell Count; Corpus Striatum; Disease Models, Ani | 2003 |
Neonatal 6-hydroxydopamine administration to mice is fatal.
Topics: Adrenergic Agents; Animals; Animals, Newborn; Aromatic-L-Amino-Acid Decarboxylases; Behavior, Animal | 2002 |
Sympathetic nervous system inhibition increases hepatic progenitors and reduces liver injury.
Topics: Adrenergic alpha-Antagonists; Animals; Antioxidants; Body Weight; Diet; Fatty Liver; Hepatocytes; Li | 2003 |
Recombinant adeno-associated viral vector (rAAV) delivery of GDNF provides protection against 6-OHDA lesion in the common marmoset monkey (Callithrix jacchus).
Topics: Adenoviridae; Animals; Body Weight; Callithrix; Cell Count; Genetic Vectors; Glial Cell Line-Derived | 2003 |
[Effects of sympathectomy on the blood pressure of young Wistar rats fed with high-sucrose diet].
Topics: Angiotensin II; Animal Feed; Animals; Blood Glucose; Blood Pressure; Body Weight; Dietary Sucrose; I | 2003 |
Neurochemical correlates of sparing from motor deficits in rats depleted of striatal dopamine as weanlings.
Topics: Age Factors; Animals; Body Weight; Brain Mapping; Corpus Striatum; Dopamine; Dopamine Antagonists; M | 2003 |
Neuroprotective effects of vascular endothelial growth factor (VEGF) upon dopaminergic neurons in a rat model of Parkinson's disease.
Topics: Adrenergic Agents; Amphetamine; Animals; Behavior, Animal; Body Weight; Brain; Capsules; Cell Count; | 2004 |
Accumbens dopamine and the regulation of effort in food-seeking behavior: modulation of work output by different ratio or force requirements.
Topics: Adrenergic Agents; Analysis of Variance; Animals; Body Weight; Brain Chemistry; Chromatography, High | 2004 |
Cholecystokinin tetrapeptide improves water maze performance of neonatally 6-hydroxydopamine-lesioned young rats.
Topics: Animals; Animals, Newborn; Body Weight; Brain Chemistry; Dopamine; Female; Hyperkinesis; Maze Learni | 2004 |
Neurorescue effects of VEGF on a rat model of Parkinson's disease.
Topics: Adrenergic Agents; Amphetamine; Analysis of Variance; Animals; Behavior, Animal; Body Weight; Brain; | 2005 |
Caffeine restores feeding response to 2-deoxy-D-glucose in 6-hydroxydopamine-treated rats.
Topics: Animals; Blood Glucose; Body Weight; Caffeine; Deoxyglucose; Eating; Feeding Behavior; Male; Oxidopa | 1977 |
Selective acetylcholine and dopamine lesions in neonatal rats produce distinct patterns of cortical dendritic atrophy in adulthood.
Topics: Acetylcholine; Animals; Animals, Newborn; Antibodies, Monoclonal; Atrophy; Body Weight; Brain Chemis | 2005 |
Nicotine's attenuation of body weight involves the perifornical hypothalamus.
Topics: Animals; Body Weight; Catecholamines; Eating; Epinephrine; Hypothalamus; Male; Nicotine; Nicotinic A | 2007 |
Transforming growth factor-beta in the brain enhances fat oxidation via noradrenergic neurons in the ventromedial and paraventricular hypothalamic nucleus.
Topics: Analysis of Variance; Animals; Body Weight; Brain Chemistry; Energy Metabolism; Fats; Male; Microdia | 2007 |
The role of anxiety in the development of levodopa-induced dyskinesias in an animal model of Parkinson's disease, and the effect of chronic treatment with the selective serotonin reuptake inhibitor citalopram.
Topics: Adrenal Cortex Hormones; Amphetamine; Animals; Anxiety; Blotting, Western; Body Weight; Central Nerv | 2008 |
Protective effects of SUN N8075, a novel agent with antioxidant properties, in in vitro and in vivo models of Parkinson's disease.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Adrenergic Agents; Analysis of Variance; Aniline Compo | 2008 |
6-Hydroxydopamine produces a weight increase in toads.
Topics: Adrenergic Fibers; Animals; Body Weight; Bufo marinus; Catecholamines; Dose-Response Relationship, D | 1983 |
The development of brain biogenic amines, cyclic nucleotides and hyperactivity in 6-OHDA-treated rat pups.
Topics: Aging; Animals; Biogenic Amines; Body Weight; Brain Chemistry; Cyclic AMP; Cyclic GMP; Dopamine; Hyd | 1983 |
The adenylate cyclase activity in heart membranes from normotensive and spontaneously hypertensive rats, after chemical sympathectomy, suggests the presence of presynaptic secretin receptors.
Topics: Adenylyl Cyclases; Animals; Blood Pressure; Body Weight; Heart; Heart Rate; Hydroxydopamines; Hypert | 1983 |
Impaired growth of the cerebral cortex of rats treated neonatally with 6-hydroxydopamine under different environmental conditions.
Topics: Animals; Animals, Newborn; Body Weight; Cerebral Cortex; Clonidine; Environment; Hydroxydopamines; N | 1983 |
Effects of d-amphetamine and apomorphine upon operant behavior and schedule-induced licking in rats with 6-hydroxydopamine-induced lesions of the nucleus accumbens.
Topics: Animals; Apomorphine; Behavior, Animal; Body Weight; Brain Chemistry; Conditioning, Operant; Dextroa | 1983 |
Open-field behavior in dopamine-depleted rat pups and their mothers.
Topics: Aging; Animals; Body Weight; Brain Chemistry; Dopamine; Female; Hydroxydopamines; Male; Maternal Beh | 1983 |
Impaired acquisition of an operant response in young rats depleted of brain dopamine in neonatal life.
Topics: Animals; Animals, Newborn; Body Weight; Brain Chemistry; Catecholamines; Conditioning, Operant; Dopa | 1983 |
Psychoneuroendocrine effects of neurotoxic lesions in the septum and striatum of rats.
Topics: Animals; Behavior, Animal; Body Weight; Brain; Corpus Striatum; Dopamine; Female; Hormones; Hydroxyd | 1983 |
Feeding, activity, and body temperature following 6-hydroxydopamine lesions in diabetes (db/db) mice.
Topics: Animals; Body Composition; Body Temperature; Body Weight; Brain; Catecholamines; Diabetes Mellitus, | 1983 |
Attack stress and IgE antibody production in rats.
Topics: Adrenal Glands; Animals; Antibodies, Anti-Idiotypic; Body Weight; Corticosterone; Hydroxydopamines; | 1983 |
Six-hydroxydopamine induced hyperactivity: neither sex differences nor caffeine stimulation are found.
Topics: Aging; alpha-Methyltyrosine; Animals; Body Weight; Brain; Brain Chemistry; Caffeine; Catecholamines; | 1984 |
Lithium attenuates the development of lesion-induced behavioral supersensitivity to apomorphine.
Topics: Animals; Apomorphine; Body Weight; Corpus Striatum; Dopamine; Hydroxydopamines; Lithium; Male; Movem | 1984 |
Effect of l-dopa or bromocriptine on feeding and motor behavior of rats with lesions in the globus pallidus.
Topics: Animals; Body Weight; Brain Mapping; Bromocriptine; Carbidopa; Drinking; Eating; Globus Pallidus; Hy | 1984 |
The importance of the peripeduncular nucleus in the neuroendocrine control of sexual behavior and milk ejection in the rat.
Topics: Animals; Body Weight; Dopamine; Female; Hydroxydopamines; Ibotenic Acid; Lactation; Male; Milk Eject | 1984 |
A role for amine accumulation in the syndrome of ingestive deficits following lateral hypothalamic lesions.
Topics: Animals; Appetite; Body Weight; Brain; Catecholamines; Dopamine; Eating; Energy Intake; Hydroxydopam | 1984 |
Amygdalar noradrenergic and dopaminergic mechanisms in the regulation of hunger and thirst-motivated behavior.
Topics: Amygdala; Animals; Behavior, Animal; Body Weight; Desipramine; Dopamine; Drinking; Eating; Hunger; H | 1982 |
Environmental and biologic interactions on behavior: effects of artificial rearing in rat pups treated with 6-hydroxydopamine.
Topics: Animals; Arousal; Avoidance Learning; Body Weight; Brain Chemistry; Dopamine; Escape Reaction; Habit | 1982 |
Exercise-induced glycogenolysis in sympathectomized rats.
Topics: Adrenal Medulla; Animals; Body Temperature; Body Weight; Female; Glycogen; Hydroxydopamines; Liver G | 1982 |
The behavioural effects of intrahypothalamic multistage versus single injections of 6-hydroxydopamine.
Topics: Animals; Behavior, Animal; Body Weight; Catecholamines; Caudate Nucleus; Consummatory Behavior; Hydr | 1982 |
Effects of 6-hydroxydopamine upon primary and secondary thymus dependent immune responses.
Topics: Adrenalectomy; Animals; Antibody Formation; Antibody-Producing Cells; Body Weight; DNA Nucleotidylex | 1982 |
Body weight changes after neurochemical manipulations of lateral amygdala: noradrenergic and dopaminergic mechanisms.
Topics: Amygdala; Animals; Body Weight; Brain Mapping; Desipramine; Dopamine; Feeding Behavior; Hydroxydopam | 1982 |
Effects of neonatal 6-hydroxydopamine treatment on cortical development in mice and rats as monitored by developmental changes of gangliosides.
Topics: Animals; Animals, Newborn; Body Weight; Cerebral Cortex; Gangliosides; Hydroxydopamines; Mice; Norep | 1982 |
Changes of cholecystokinin octapeptide tissue levels in rat brain following dopamine neuron lesions induced by 6-hydroxydopamine.
Topics: Animals; Body Weight; Brain Chemistry; Chromatography, Gel; Dopamine; Injections, Intraventricular; | 1994 |
Effect of bilateral 6-OHDA lesions of the substantia nigra on locomotor activity in the rat.
Topics: Amphetamine; Animals; Apomorphine; Body Weight; Immunohistochemistry; Levodopa; Male; Motor Activity | 1994 |
Bilateral 6-OHDA lesions of the locus coeruleus impair associative olfactory learning in newborn rats.
Topics: Analysis of Variance; Animals; Animals, Newborn; Association Learning; Body Weight; Brain Stem; Dopa | 1994 |
The effects of 6-hydroxydopamine lesions of the nucleus accumbens and the mesolimbic dopamine system on oral self-administration of ethanol in the rat.
Topics: Administration, Oral; Alcohol Drinking; Amygdala; Analysis of Variance; Animals; Body Weight; Corpus | 1993 |
Repeated administration of a selective dopamine D2 receptor agonist to 6-OHDA-lesioned rats does not affect the survival and outgrowth of intrastriatal fetal mesencephalic grafts.
Topics: Animals; Behavior, Animal; Body Weight; Cell Count; Cell Survival; Dopamine; Dopamine Agonists; Ergo | 1995 |
Influence of 6-hydroxydopamine lesion of the dopaminergic nigrostriatal pathway on the muscle tone and electromyographic activity measured during passive movements.
Topics: Animals; Ankle Joint; Body Weight; Dopamine; Electromyography; Hindlimb; Immunohistochemistry; Male; | 1996 |
Noradrenergic facilitation of the adrenocorticotropin response to stress is absent during lactation in the rat.
Topics: Adrenocorticotropic Hormone; Afferent Pathways; Animals; Animals, Suckling; Body Weight; Denervation | 1996 |
Sustained increase in rat myocardial alpha 1A-adrenoceptors induced by 6-hydroxydopamine treatment involves a decelerated receptor turnover.
Topics: Adrenergic Agents; Adrenergic alpha-Antagonists; Analysis of Variance; Animals; Body Weight; Dioxane | 1996 |
Effect of sympathetic and angiotensin-aldosterone systems on renal salt conservation in the rat.
Topics: Adrenalectomy; Aldosterone; Angiotensin Receptor Antagonists; Animals; Antihypertensive Agents; Biph | 1997 |
Tissue-specific regulation of fat cell lipolysis by NPY in 6-OHDA-treated rats.
Topics: Adipocytes; Animals; Appetite Stimulants; Body Weight; Cell Size; Eating; Fasting; Female; Lipolysis | 1997 |
Recovery of function is associated with increased spine density in cortical pyramidal cells after frontal lesions and/or noradrenaline depletion in neonatal rats.
Topics: Animals; Animals, Newborn; Body Weight; Forelimb; Frontal Lobe; Male; Maze Learning; Neurites; Norep | 1997 |
Effect of catecholaminergic lesions of medial prefrontal cortex on regulation of body weight and glucose preference.
Topics: Animals; Appetite; Body Weight; Catecholamines; Desipramine; Drug Combinations; Glucose; Male; Oxido | 1997 |
Evidence that dark-phase hyperphagia induced by neurotoxin 6-hydroxydopamine may be due to decreased leptin and increased neuropeptide Y signaling.
Topics: Adrenergic Agents; Animals; Body Weight; Circadian Rhythm; Eating; Efferent Pathways; Gene Expressio | 1998 |
CCK-8 inhibits ingestive behavior in rats with lateral hypothalamic 6-OHDA lesions.
Topics: Animals; Biogenic Monoamines; Body Weight; Brain Chemistry; Depression, Chemical; Eating; Hypothalam | 1998 |
Behavioral and cellular protection of rat dopaminergic neurons by an adenoviral vector encoding glial cell line-derived neurotrophic factor.
Topics: Adenoviridae; Amphetamine; Animals; Behavior, Animal; Body Weight; Cell Survival; Corpus Striatum; D | 1998 |
Modulatory role of adrenergic nerves on dexamethasone-induced islet cell NPY expression in the rat: evidence from chemical sympathectomy.
Topics: Adrenergic Agents; Animals; Body Weight; Cell Size; Dexamethasone; Gene Expression; Immunohistochemi | 1999 |
Protection and regeneration of nigral dopaminergic neurons by neurturin or GDNF in a partial lesion model of Parkinson's disease after administration into the striatum or the lateral ventricle.
Topics: Amphetamine; Animals; Antibodies; Apomorphine; Atrophy; Body Weight; Cerebral Ventricles; Corpus Str | 1999 |
A therapeutic role for melatonin antagonism in experimental models of Parkinson's disease.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Animals; Biological Availability; Body Weight; Circadi | 1999 |
Sequential administration of GDNF into the substantia nigra and striatum promotes dopamine neuron survival and axonal sprouting but not striatal reinnervation or functional recovery in the partial 6-OHDA lesion model.
Topics: Animals; Axonal Transport; Axons; Body Weight; Cell Survival; Corpus Striatum; Dopamine; Female; For | 2000 |
Systemic administration of the propargylamine CGP 3466B prevents behavioural and morphological deficits in rats with 6-hydroxydopamine-induced lesions in the substantia nigra.
Topics: Animals; Antibodies; Apoptosis; Behavior, Animal; Body Weight; Denervation; Dopamine; Exploratory Be | 2000 |
Alterations of conditioned taste aversion after microiontophoretically applied neurotoxins in the medial prefrontal cortex of the rat.
Topics: Animals; Avoidance Learning; Body Weight; Conditioning, Psychological; Drinking; Eating; Excitatory | 2000 |
Postnatal inorganic lead exposure decreases the number of spontaneously active midbrain dopamine neurons in the rat.
Topics: Animals; Body Weight; Cell Count; Cell Death; Dopamine; Electrophysiology; Lead; Male; Mesencephalon | 2001 |
Effects of chemical sympathectomy by means of 6-hydroxydopamine on insulin secretion and islet morphology in alloxan-diabetic mice.
Topics: Animals; Blood Glucose; Body Weight; Diabetes Mellitus, Experimental; Female; Gene Expression; Insul | 2002 |
Angiotensin converting enzyme inhibition prevents trophic and hypertensive effects of an antagonist of adenosine receptors.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Arteries; Blood Pressure; Body Weight; Captopril; | 2002 |
Excitotoxic lesions of the pedunculopontine tegmental nucleus of the rat. II. Examination of eating and drinking, rotation, and reaching and grasping following unilateral ibotenate or quinolinate lesions.
Topics: Animals; Behavior, Animal; Body Weight; Choline O-Acetyltransferase; Drinking Behavior; Feeding Beha | 1992 |
Sympathetic denervation blocks blood pressure elevation in episodic hypoxia.
Topics: Animals; Blood Pressure; Body Weight; Epinephrine; Heart Rate; Hypoxia; Male; Myocardium; Norepineph | 1992 |
Regulatory behaviour, exploration and locomotion following NMDA or 6-OHDA lesions in the rat nucleus accumbens.
Topics: Animals; Apomorphine; Body Weight; Brain Mapping; Dextroamphetamine; Dopamine; Dose-Response Relatio | 1992 |
Neonatal brain dopamine depletion and the cortical and behavioral consequences of enriched postweaning environment.
Topics: Animals; Animals, Newborn; Anxiety; Behavior, Animal; Body Weight; Brain Chemistry; Catecholamines; | 1992 |
Differential effects of 6-hydroxydopamine-induced ablation of peripheral and central adrenergic axons on C-1300 murine neuroblastoma tumor growth and catecholamine concentration in the A/J mouse.
Topics: Animals; Axons; Body Weight; Catecholamines; Chromatography, High Pressure Liquid; Injections, Intra | 1992 |
Baroreflex changes produced by serotonergic or catecholaminergic lesions in the rat nucleus tractus solitarius.
Topics: 5,7-Dihydroxytryptamine; Animals; Blood Pressure; Body Weight; Brain; Drug Interactions; Electric St | 1992 |
Neonatal 6-OHDA lesions and rearing in complex environments: regional effects on adult brain 14C-2-deoxyglucose uptake revealed by exposure to novel stimulation.
Topics: Animals; Animals, Laboratory; Animals, Newborn; Body Weight; Brain; Culture Techniques; Deoxyglucose | 1992 |
Suppression of clinical weakness in experimental autoimmune encephalomyelitis associated with weight changes, and post-decapitation convulsions after intracisternal-ventricular administration of 6-hydroxydopamine.
Topics: Animals; Body Weight; Brain; Catecholamines; Cerebral Ventricles; Cisterna Magna; Decerebrate State; | 1990 |
Chemical sympathectomy alters the development of hypertension in miniature swine.
Topics: Animals; Blood Pressure; Body Weight; Catecholamines; Desoxycorticosterone; Female; Hydroxydopamines | 1991 |
The effect of chronic L-dopa treatment on the recovery of motor function in 6-hydroxydopamine-lesioned rats receiving ventral mesencephalic grafts.
Topics: Animals; Apomorphine; Body Weight; Carbidopa; Corpus Striatum; Drinking; Female; Fetal Tissue Transp | 1991 |
Contribution of forebrain noradrenaline innervation to the central circulatory effects of alpha-methyldopa and 6-hydroxydopamine.
Topics: Animals; Blood Pressure; Body Weight; Brain; Brain Chemistry; Catecholamines; Cisterna Magna; Female | 1991 |
Trophic control of the ornithine decarboxylase/polyamine system in neonatal rat brain regions: lesions caused by 6-hydroxydopamine produce effects selective for cerebellum.
Topics: Animals; Animals, Newborn; Biogenic Polyamines; Body Weight; Cerebellum; Cerebral Cortex; Hydroxydop | 1990 |
Food intake and lateral hypothalamic self-stimulation covary after medial hypothalamic lesions or ventral midbrain 6-hydroxydopamine injections that cause obesity.
Topics: Animals; Body Weight; Brain Mapping; Eating; Female; Hydroxydopamines; Hypothalamic Area, Lateral; M | 1989 |
Development of the linkage of beta-adrenergic receptors to cardiac hypertrophy and heart rate control: neonatal sympathectomy with 6-hydroxydopamine.
Topics: Animals; Animals, Newborn; Body Weight; Cardiomegaly; Heart Rate; Hydroxydopamines; Isoproterenol; O | 1989 |
Role of sympathetic neurons in biochemical and functional development of the kidney: neonatal sympathectomy with 6-hydroxydopamine.
Topics: Animals; Animals, Newborn; Body Weight; Cyclic AMP; Female; Hydroxydopamines; Kidney; Kidney Functio | 1988 |
Central noradrenergic neurons and vascular non-collagen protein in the initial phase of two-kidney, one-clip renovascular hypertension.
Topics: Animals; Aorta; Blood Pressure; Blood Vessels; Body Weight; Catecholamines; Dopamine; Hexamethonium; | 1988 |
Rolipram, a stereospecific inhibitor of calmodulin-independent phosphodiesterase, causes beta-adrenoceptor subsensitivity in rat cerebral cortex.
Topics: Adenylyl Cyclases; Animals; Body Weight; Cerebral Cortex; Cyclic AMP; Hydroxydopamines; Male; Norepi | 1986 |
Effects of lateral hypothalamic lesions on food intake of rats during exposure to cold.
Topics: Animals; Body Temperature Regulation; Body Weight; Cold Temperature; Dopamine; Feeding Behavior; Hyd | 1985 |
Dopamine-norepinephrine interactions in the development of hyperphagia and obesity following medial hypothalamic lesions.
Topics: Animals; Body Weight; Brain Mapping; Bupropion; Dopamine; Feeding Behavior; Female; Hydroxydopamines | 1986 |
Dopamine agonist-induced stereotypic grooming and self-mutilation following striatal dopamine depletion.
Topics: Animals; Body Weight; Corpus Striatum; Dopamine; Grooming; Hydroxydopamines; Injections; Male; Nucle | 1986 |
Effect of paraventricular nucleus lesions on body weight, food intake and insulin levels.
Topics: Animals; Biogenic Amines; Blood Glucose; Body Weight; Dietary Fats; Feeding Behavior; Female; Hydrox | 1986 |
Food intake and biogenic amine concentrations in brain regions of chicks following intracerebroventricular injection of six-hydroxydopamine.
Topics: Animals; Body Weight; Brain Chemistry; Brain Stem; Chickens; Corpus Callosum; Dopamine; Eating; Epin | 1987 |
Effects of chemical sympathectomy in neonatal and adult mice on C-1300 neuroblastoma tumor growth and catecholamine content.
Topics: Age Factors; Animals; Body Weight; Catecholamines; Hydroxydopamines; Mice; Neuroblastoma; Organ Size | 1987 |
An increase in striatal Met-enkephalin-like immunoreactivity in neonatally dopamine-depleted rats.
Topics: Age Factors; Animals; Animals, Newborn; Body Weight; Corpus Striatum; Dopamine; Enkephalin, Methioni | 1988 |
[Receptor events after peripheral chemical sympathectomy].
Topics: Animals; Body Temperature; Body Weight; Dobutamine; Hydroxydopamines; Oxidopamine; Oxygen Consumptio | 1988 |
Postnatal development of rat heart during 6-hydroxydopamine or propranolol treatment.
Topics: 3-Hydroxyacyl CoA Dehydrogenases; Adenosine Triphosphatases; Age Factors; Animals; Body Weight; Crea | 1985 |
Comparative effects of infusions of 6-hydroxydopamine into nucleus accumbens and anterolateral hypothalamus induced by 6-hydroxydopamine on the response to dopamine agonists, body weight, locomotor activity and measures of exploration in the rat.
Topics: Animals; Apomorphine; Body Weight; Brain Chemistry; Dextroamphetamine; Exploratory Behavior; Humans; | 1985 |
Effects of 6-hydroxydopamine-induced catecholamine depletion on shock-precipitated wall climbing of infant rat pups.
Topics: Animals; Animals, Suckling; Behavior, Animal; Body Temperature; Body Weight; Brain Chemistry; Dopami | 1985 |
Ibotenic acid lesions of the lateral hypothalamus: comparison with 6-hydroxydopamine-induced sensorimotor deficits.
Topics: Animals; Body Weight; Functional Laterality; Hydroxydopamines; Hypothalamic Area, Lateral; Ibotenic | 1985 |
Growth and plasticity of rat cerebral cortex after central noradrenaline depletion.
Topics: Animal Husbandry; Animals; Body Weight; Brain; Cerebral Cortex; Dopamine; Environment; Hydroxydopami | 1985 |
Sympathectomy inhibits growth of a murine plasmacytoma tumor.
Topics: Animals; Animals, Newborn; Benzylamines; Body Temperature; Body Weight; Dopamine beta-Hydroxylase; F | 1985 |
Tolerance pattern to amphetamine anorexia after selective lesions in the hypothalamic dopaminergic projection.
Topics: Animals; Anorexia; Body Weight; Dextroamphetamine; Dopamine; Drug Tolerance; Energy Intake; Feeding | 1985 |
Effects of chronic dietary lithium on behavioral indices of dopamine denervation supersensitivity in the rat.
Topics: Animals; Apomorphine; Behavior, Animal; Body Weight; Caudate Nucleus; Diet; Hydroxydopamines; Lithiu | 1985 |
Disappearance of hoarding behavior after 6-hydroxydopamine lesions of the mesolimbic dopamine neurons and its reinstatement with L-dopa.
Topics: Animals; Behavior, Animal; Body Weight; Brain Mapping; Dopamine; Drinking Behavior; Feeding Behavior | 1985 |